Taken together, our study clearly investigates the expression levels, clinical significances, and functions of Runx2, and identifies its upstream regulator Zic2 and downstream target NOLC1 in ccRCC. This evidence concerns the gene ZIC2 and nonpapillary renal cell carcinoma.